Personalized smartphone support to help adults in Laos quit smoking
Official title: Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-11418143 · Data updated 2026-11-12
This project offers a personalized smartphone program to help adult smokers in Laos stop using cigarettes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | September 1, 2020 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $85,126 |
| NIH project number | 3R33CA253600-05S1 |
| Project ID | NIH-11418143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults in Lao PDR who currently smoke cigarettes and own a smartphone with mobile service.
✕Less likely to help
People without a smartphone or reliable mobile service, users of non-cigarette tobacco products not targeted by the program, or those not ready to try quitting may not benefit from this intervention.
What this research studies
You would get a fully automated, interactive program on your smartphone that sends tailored messages and behavioral tips to support quitting. The content is adapted for people in Laos and delivered through the Insight™ mobile platform. The team will enroll adult smokers, send messages and support over time, and follow up to see who reaches abstinence. The approach builds on proven text-message and mHealth methods but is being customized and tested for local needs in Lao PDR.
Why it matters
Potential benefit: If successful, this could make quitting support more accessible across Laos and help many people stop smoking, lowering future health risks.
How similar studies have gone: Text-message and other mHealth smoking-cessation programs have helped people quit in many countries, though applying them in Laos is relatively new.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Bui, Thanh C. — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Bui, Thanh C.
Related research
Other NIH-funded projects on the same topics.
-
Primary care research network in Oklahoma to boost rural patient trials
A nationwide NIH-supported effort to strengthen Oklahoma’s primary care research network so doctors can run big clinical trials and real‑world studies in rural communities.
-
N-myristoylation and DNA damage response in Alzheimer’s disease
A study to understand how a protein modification called myristoylation affects the DNA damage response in people who have Alzheimer’s-related conditions.
-
Genetically engineered mouse model to study and treat high-risk pediatric rhabdomyosarcoma
A research project aims to create mouse models that mimic high-risk pediatric rhabdomyosarcoma and test therapies that target the NOTCH1 pathway to slow or stop tumor growth.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Vascular signals from brain blood vessels influence immune-suppressing cells in glioblastoma
This grant explores how blood vessel cells in glioblastoma shape immune cells to help the tumor grow, with the aim of making immunotherapies work better for patients.
-
TFEB as a key switch to keep muscles healthy as we age
A study in aging adults and aging muscle tissues looks at whether boosting TFEB can improve how muscles maintain themselves and recover after disuse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.